Deep search
Search
Images
Videos
Maps
News
Shopping
Copilot
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
HIV, Gilead
Gilead reportedly settles CDC patent dispute over HIV drugs
Gilead Sciences (NASDAQ:GILD) has reportedly settled a patent lawsuit with the federal government over its HIV drugs Truvada and Descovy. The lawsuit stemmed from research Gilead (NASDAQ:GILD) conducted with the U.
Gilead Sciences, US government settle patent case over HIV prevention drugs
Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court.
Biden administration and Gilead settle long-running battle over patents for HIV PrEP pills
After years of sparring, the Biden administration and Gilead Sciences have settled a contentious lawsuit over patents for a pair of HIV prevention pills.
Medpage Today on MSN
2d
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
"The CDC must be investigated for its misuse of PEPFAR funds," said Sen. Jim Risch (R-Idaho), following a report that funds ...
1d
Unlocking the Immune Chain Reaction: Surprising Findings in HIV Vaccines
Scientists discovered that repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes ...
1d
on MSN
A chain reaction: HIV vaccines can lead to antibodies against antibodies
Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will ...
1d
on MSN
"Glimmer of hope": STI surge shows first signs of slowing in decades. What’s behind the trend?
A new treatment for sexually-transmitted diseases seems to be slowing an STI epidemic — but not everyone can get it ...
Managed Healthcare Executive
1d
The Biggest HIV Stories to Follow in 2025
Jose Abrigo, Esq., HIV Project Director of the Lambda Legal Defense and Education Fund explains the biggest HIV issues anticipated this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback